Brimonidine: study card

Brimonidine — Alpha-2 adrenergic agonist. Study the mechanism, listed uses and warnings from the US label on one sourced card.

Generic name: Brimonidine
Class: Alpha-2 adrenergic agonist
Mechanism: Relatively selective alpha-2 agonist. Studies in animals and humans suggest reduced aqueous humor production and increased uveoscleral outflow lower intraocular pressure.
Used for: Open-angle glaucoma; Ocular hypertension
Common side effects: Allergic conjunctivitis; Conjunctival hyperemia; Eye pruritus; Burning sensation; Oral dryness
Warnings: Potentiation of vascular insufficiency; Severe cardiovascular disease; Contraindicated under age 2
Interactions: Antihypertensives / cardiac glycosides; CNS depressants; MAO inhibitors

Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.

Read the source label ↗

Label date: 20260909 · For learning, not clinical decisions. US label and brand information; always consult the current source.

Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.

Practice

Pronunciation

Brimonidine: bri-MOE-ni-deen

Pronunciation is shown for the US English generic name.

Body system

Eye & ear · 19 Drug cards

Compare with related cards

Latanoprost

Same body system: Eye & ear

Mechanism: Prostaglandin F2-alpha analogue believed to lower intraocular pressure by increasing aqueous-humor outflow; animal and human studies suggest mainly increased uveoscleral outflow.

On both cards: Used for — Open-angle glaucoma; Ocular hypertension · Common side effects — Conjunctival hyperemia

Only on the Latanoprost card: Common side effects — Blurred vision; Burning and stinging; Foreign body sensation; Increased iris pigmentation · Warnings — Iris / eyelid pigmentation (iris likely permanent); Eyelash changes; Hypersensitivity incl. benzalkonium chloride

Timolol maleate (ophthalmic)

Same body system: Eye & ear

Mechanism: Non-selective beta1/beta2 adrenergic receptor blocker without significant intrinsic sympathomimetic or membrane-stabilizing activity.

On both cards: Used for — Open-angle glaucoma; Ocular hypertension

Only on the Timolol maleate (ophthalmic) card: Common side effects — Burning / stinging on instillation; Headache; Asthenia / fatigue; Bradycardia · Warnings — Contraindicated with bronchial asthma or its history, or severe COPD; Contraindicated with sinus bradycardia or second-/third-degree AV block; Overt cardiac failure and cardiogenic shock are contraindications · Interactions — Oral beta-blockers; Calcium antagonists; CYP2D6 inhibitors

Dorzolamide

Same body system: Eye & ear

Mechanism: Inhibits carbonic anhydrase (mainly CA-II) in the eye, lowering intraocular pressure.

On both cards: Used for — Open-angle glaucoma; Ocular hypertension

Only on the Dorzolamide card: Common side effects — Ocular burning / stinging; Bitter taste; Superficial punctate keratitis; Ocular allergic reaction · Warnings — Sulfonamide hypersensitivity; Bacterial keratitis; Corneal endothelium effects · Interactions — Oral carbonic anhydrase inhibitors

An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.